NM_000203.5:c.1205G>A
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM3PP4
This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.1205G>A (p.Trp402Ter) variant in IDUA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 9 out of a total of 14 exons, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism. Complete loss of IDUA activity was confirmed when the variant was transiently expressed in COS-7 cells (PMID:11735025) (PVS1). This is the most common variant to be identified in patients with mucopolysaccharidosis type 1 (MPS1) in the United States (45% of alleles), Mexico (29%), Colombia (50%), Brazil (29%), the United Kingdom (45%), the Netherlands (42%), Germany (50%), the Czech Republic and Slovakia (33%), Spain (62%) and Australia (34%) (reviewed in PMID:29393969). At least 38 homozygotes (PMID:1301196, 28752568) (max PM3 points = 2 x 0.5 = 1 point for homozygotes), and at least 73 individuals who are compound heterozygous for the variant and a second variant in IDUA, including another well-known pathogenic variant, p.Gln70Ter, have been reported (PMID:1301941, 11735025, 28752568, 30809705). The allelic evidence from these compound heterozygous patients will be used to support the classification of the other variant and is not included here to avoid circular logic (PM3 based on evidence from homozygotes). Patients are reported with detailed clinical features of MPS I or elevated urine GAGs in addition to documentation of laboratory values showing deficient IDUA activity (PMID:1301941, 11735025, 30809705) (PP4). A knock in mouse, homozygous for a variant analogous to p.Trp402Ter (mouse Idua Trp392Ter) was reported to have a phenotype that closely correlates with features in humans patients with MPS1 (PMID:19751987). The highest population minor allele frequency in gnomAD v4.1.0 is 0.001555 (1749/1124730 alleles) in the European non-Finnish population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.00025) and lower than the threshold for BS1 (>0.0025). Therefore, no population codes are met. Additional data is available in the literature but the classification of pathogenic has already been reached. There is a ClinVar entry for this variant (Variation ID: 11908). In summary, this variant is the most frequently reported variant in individuals with MPS1 and meets the criteria to be classified as pathogenic for this disorder. IDUA-specific ACMG/AMP criteria met, as specified by the ClinGen Lysosomal Diseases VCEP (Specifications Version 1.0.0): PVS1, PM3, PP4.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on January 3, 2025) LINK:https://erepo.genome.network/evrepo/ui/classification/CA220498/MONDO:0001586/091
Frequency
Consequence
NM_000203.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 1Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Scheie syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Hurler syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Hurler-Scheie syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000203.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IDUA | TSL:2 MANE Select | c.1205G>A | p.Trp402* | stop_gained | Exon 9 of 14 | ENSP00000425081.2 | P35475-1 | ||
| IDUA | TSL:1 | c.1205G>A | p.Trp402* | stop_gained | Exon 9 of 14 | ENSP00000247933.4 | P35475-1 | ||
| IDUA | c.1280G>A | p.Trp427* | stop_gained | Exon 10 of 15 | ENSP00000632448.1 |
Frequencies
GnomAD3 genomes AF: 0.000860 AC: 130AN: 151238Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000585 AC: 53AN: 90548 AF XY: 0.000489 show subpopulations
GnomAD4 exome AF: 0.00131 AC: 1750AN: 1334448Hom.: 0 Cov.: 34 AF XY: 0.00130 AC XY: 852AN XY: 657900 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000859 AC: 130AN: 151342Hom.: 0 Cov.: 33 AF XY: 0.000744 AC XY: 55AN XY: 73930 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at